Non-invasive Glucose Monitoring Devices Market Analysis North America, Europe, Asia, Rest of World (ROW) - US, Germany, UK, India, China - Size and Forecast 2024-2028

Published: Nov 2023 Pages: 158 SKU: IRTNTR70187

Non-invasive Glucose Monitoring Devices Market 2024-2028

The Global Non-Invasive Glucose Monitoring Devices market size is estimated to grow by USD 25.98 million at a CAGR of 15.46% between 2023 and 2028. 

There has been an increasing demand for non-invasive procedures across the globe. In addition, the demand for non-invasive monitoring and diagnostic procedures is increasing due to their ease of operation, fewer side effects, and minimum discomfort. Moreover, non-invasive glucose monitoring devices are used for monitoring glucose levels. Furthermore, they are used as alternatives to conventional blood glucose monitoring devices as the latter method causes pain and discomfort to patients. Hence, such factors are positively impacting the market.

Technavio has segmented the market into Product, End-user, and Geography

  • The product segment is classified into wearable and non-wearable
  • The end-user segment is classified into home care settings, hospitals, and clinics
  • The geography segment includes key regions such as North America, Europe, Asia, and the Rest of the World (ROW)

It also includes an in-depth analysis of drivers, trends, and challenges. Our report examines historical data from 2018-2022, besides analyzing the current market scenario.

What will be the Size of the Non-invasive Glucose Monitoring Devices Market During the Forecast Period?

To learn more about this report, Request Free Sample

Non-invasive Glucose Monitoring Devices Market Segmentation by Product, End-user, and Geography Analysis

Product Analysis

Wearable

The wearable segment is estimated to witness significant growth during the forecast period. In this segment, several start-ups are increasing their efforts by coming up with an innovative product pipeline, which is likely to spur the growth of the segment. Therefore, a strong product pipeline by new companies, continuous technological advancements by key companies, and the growing demand for non-invasive monitoring of glucose levels is likely to augment the demand for wearable non-invasive glucose monitoring devices, which, in turn, will contribute to the market growth.

Get a glance at the market contribution of various segments Download PDF Sample

The wearable segment was the largest segment and was valued at USD 8.47 million in 2018. Moreover, wearable non-invasive glucose monitoring devices comprise transdermal sensors that pass a near-infrared (NI) light through the skin layer to measure glucose levels using optical approaches. In addition, the wearable product segment accounts for the largest market share in the global non-invasive glucose monitoring devices market which is fuelled by factors such as the increasing prevalence of diabetes, technological advancements, the presence of strong companies, and new product launches that will fuel the growth of the segment during the forecast period.

End-user Analysis

Home care settings

In a home setting segment, non-invasive devices can help minimize the risk of infections associated with invasive monitoring techniques, thereby promoting a safer environment for individuals managing their health at home. In addition, regular monitoring of glucose levels at home enables better disease management. Moreover, patients can make informed decisions about their diet, exercise, and medication based on real-time data, leading to improved control of their condition. Furthermore, non-invasive glucose monitoring devices that are user-friendly and less intrusive can encourage better patient engagement and compliance in the homecare setting. Hence, such factors are fuelling the growth of this segment which in turn will drive the market growth during the forecast period.

Hospitals

The hospitals segment comprises multi-specialty hospitals and private hospital groups, which function through sponsorships from governments or private entities. In addition, these hospitals have around 500 hospital beds with both inpatient and outpatient services. Moreover, they purchase medical equipment and consumables in bulk and work closely with suppliers and government bodies. Furthermore, they also have a well-equipped medical infrastructure to cater to the needs of patients. Hence, such factors are fuelling the growth of this segment which in turn will drive the market growth during the forecast period.

Regional Analysis

For more insights about the market share of various regions Download PDF Sample now!

North America is estimated to contribute 48% to the growth of the global market during the forecast period. Technavio’s analysts have elaborately explained the regional trends and drivers that will shape the market during the forecast period. The non-invasive glucose monitoring devices market in North America will grow at a moderate rate due to factors such as the increasing prevalence of diabetes, the rising number of product launches, the growing presence of regional and global vendors, and initiatives by government and non-profit organizations to create awareness about diabetes prevention and management. Moreover, patients with diabetes require glucose meters to monitor their glucose levels. Furthermore, the rising prevalence of diabetes will increase the need for glucose meters, which, in turn, will augment the adoption of non-invasive glucose monitoring devices during the forecast period.

Buy Full Report Now

Key Non-invasive Glucose Monitoring Devices Market Players 

Companies are implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market. The report also includes detailed analyses of the competitive landscape of the market and information about 20 market companies, including:

Abbott Laboratories: The company offers non-invasive glucose devices such as freestyle libre 2 continuous.

  • Ascensia Diabetes Care Holdings AG
  • BlueSemi
  • BoydSense SAS
  • Cnoga
  • Dexcom Inc.
  • DiaMonTech AG
  • Eser Co.
  • Gluco Rx Ltd.
  • Glucowise
  • F. Hoffmann La Roche Ltd.
  • Informed Data Systems Inc. and One Drop.
  • Medtronic Plc
  • Meta Materials Inc.
  • Nemaura Medical Inc.
  • Platinum Equity Advisors LLC
  • Rite Aid Corp.
  • Taiwan Biophotonic Co.
  • Tandem Diabetes Care Inc.
  • Walgreens Boots Alliance Inc.

Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.

Non-invasive Glucose Monitoring Devices Market: Key Drivers, Trends, Challenges, and Customer Landscape

There are multiple factors influencing market growth. Our researchers analyzed the data with 2022 as the base year, along with the key drivers, trends, and challenges. 

Key Non-invasive Glucose Monitoring Devices Market Drivers

The increasing prevalence of diabetes and the growing number of government programs for non-invasive treatments are the key factors driving the market growth. The growing geriatric population is also a significant contributor to the diabetic population worldwide. In addition, individuals in these age groups are sensitive to invasive diagnostic or monitoring procedures. Furthermore, these factors are significantly increasing the sales of non-invasive devices to monitor blood glucose levels.

Moreover, sedentary lifestyles such as physical inactivity and obesity are other factors responsible for the increasing prevalence of diabetes. In addition, companies are also launching new products to expand their product portfolios and improve their market visibility. Furthermore, the growing number of awareness programs to create awareness about preventive care and the regular monitoring of glucose levels for diabetes management will drive market growth during the forecast period.

Significant Non-invasive Glucose Monitoring Devices Market Trends

The integration of AI and RADAR technology in glucose monitoring will fuel the market growth. The integration of data received from digital medical devices with mobile applications enables end-users to easily monitor body parameters, such as changes in glucose levels. In addition, universities across the world are focusing on integrating AI and RADAR systems for monitoring and diagnosis of chronic diseases such as diabetes. Furthermore, researchers are developing non-invasive glucose monitoring devices by combining RADAR and AI technologies, which would enable people with diabetes to monitor their blood glucose levels. 

Moreover, with the advent of technologies, such as AI and RADAR technology, many companies are considering incorporating blood glucose monitoring devices with these technologies. In addition, companies are collaborating with IT companies for data management and the development of tools and software for easier diabetes management. Furthermore, technologies will eliminate the need for finger pricking. Also, end-users can easily retrieve data. Hence, the integration of AI and RADAR technology in glucose monitoring devices is one of the key non-invasive blood glucose monitoring devices market trends fuelling the market growth during the forecast period.

Major Non-invasive Glucose Monitoring Devices Market Challenges

High costs associated with non-invasive glucose monitoring devices are a major challenge for market growth. The costs associated with non-invasive glucose monitoring are higher when compared to conventional blood glucose monitoring devices. As a result, this can increase the cost burden on patients. Furthermore, the average annual cost of non-invasive glucose monitoring devices ranges between USD 1,200 and USD 2,300, depending on the new technology and brand preference. 

Moreover, they also need software tools that can capture data and send it to end users. In addition, this increases the overall cost of the complete system. Furthermore, the high costs associated with non-invasive glucose monitoring devices impact their adoption and coverage, especially in developing countries. Hence, the high cost of non-invasive glucose monitoring devices compared with conventional finger-pricking glucometers is a major hindering factor for the market growth during the forecast period.

Buy Now Full Report

Key Non-invasive Glucose Monitoring Devices Market Customer Landscape

The market report includes the adoption lifecycle of the market, covering from the innovator’s stage to the laggard’s stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their growth strategies.

Global Non-invasive Glucose Monitoring Devices Market Customer Landscape

Segment Overview

The non-invasive glucose monitoring devices market report forecasts market growth by revenue at global, regional & country levels and provides an analysis of the latest trends and growth opportunities from 2018 to 2028. 

  • Product Outlook
    • Wearable
    • Non-wearable
  • End-user Outlook
    • Home care settings
    • Hospitals
    • Clinics
  • Geography Outlook
    • North America
      • The U.S.
      • Canada
    • Europe
      • U.K.
      • Germany
      • France
      • Rest of Europe
    • Asia
      • China
      • India
    • Rest of the World (ROW)
      • Australia
      • Argentina
      • Brazil
         

Non-invasive Glucose Monitoring Devices Market Scope

Report Coverage

Details

Page number

158

Base year

2023

Historic period

2018-2022

Forecast period

2024-2028

Growth momentum & CAGR

Accelerate at a CAGR of 15.46%

Market Growth 2024-2028

USD 25.98 million

Market structure

Fragmented

YoY growth 2023-2024(%)

15.07

Regional analysis

North America, Europe, Asia, and the Rest of the World (ROW)

Performing market contribution

North America at 48%

Key countries

US, Germany, UK, India, and China

Competitive landscape

 Leading Vendors, Market Positioning of Vendors, Competitive Strategies, and Industry Risks

Key companies profiled

Abbott Laboratories, Ascensia Diabetes Care Holdings AG, BlueSemi, BoydSense SAS, Cnoga, Dexcom Inc., DiaMonTech AG, Eser Co., Gluco Rx Ltd., Glucowise, F. Hoffmann La Roche Ltd., Informed Data Systems Inc. and One Drop., Medtronic Plc, Meta Materials Inc., Nemaura Medical Inc., Platinum Equity Advisors LLC, Rite Aid Corp., Taiwan Biophotonic Co., Tandem Diabetes Care Inc., and Walgreens Boots Alliance Inc.

Market dynamics

Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, and Market condition analysis for the forecast period.

Customization purview

If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.

Download Sample PDF at your Fingertips

What are the Key Data Covered in this Non-invasive Glucose Monitoring Devices Market Research Report?

  • CAGR of the market during the forecast period
  • Detailed information on factors that will drive the growth of the non-invasive glucose monitoring devices market between 2024 and 2028
  • Precise estimation of the non-invasive glucose monitoring devices market size and its contribution to the market in focus on the parent market
  • Detailed analysis of customer landscape covering Diver of price sensitivity, Adoption of the lifecycle, and key purchase criteria 
  • Companies landscape comparing criticality of inputs and factors of differentiation
  • Exclusive Matrix on companies position and classification
  • Accurate predictions about upcoming trends and changes in consumer behavior
  • Growth of the market across North America, Europe, Asia, and the Rest of the World (ROW)
  • A thorough analysis of the market’s competitive landscape and detailed information about companies
  • Comprehensive analysis of factors that will challenge the growth of non-invasive glucose monitoring devices market companies

We can help! Our analysts can customize this market research report to meet your requirements. Get in touch

1 Executive Summary

  • 1.1 Market overview
    • Exhibit 01: Executive Summary – Chart on Market Overview
    • Exhibit 02: Executive Summary – Data Table on Market Overview
    • Exhibit 03: Executive Summary – Chart on Global Market Characteristics
    • Exhibit 04: Executive Summary – Chart on Market by Geography
    • Exhibit 05: Executive Summary – Chart on Market Segmentation by Product
    • Exhibit 06: Executive Summary – Chart on Market Segmentation by End-user
    • Exhibit 07: Executive Summary – Chart on Incremental Growth
    • Exhibit 08: Executive Summary – Data Table on Incremental Growth
    • Exhibit 09: Executive Summary – Chart on Vendor Market Positioning

2 Market Landscape

  • 2.1 Market ecosystem
    • Exhibit 10: Parent market
    • Exhibit 11: Market Characteristics

3 Market Sizing

  • 3.1 Market definition
    • Exhibit 12: Offerings of vendors included in the market definition
  • 3.2 Market segment analysis
    • Exhibit 13: Market segments
  • 3.3 Market size 2023
    • 3.4 Market outlook: Forecast for 2023-2028
      • Exhibit 14: Chart on Global - Market size and forecast 2023-2028 ($ million)
      • Exhibit 15: Data Table on Global - Market size and forecast 2023-2028 ($ million)
      • Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
      • Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)

    4 Historic Market Size

    • 4.1 Global non-invasive glucose monitoring devices market 2018 - 2022
      • Exhibit 18: Historic Market Size – Data Table on global non-invasive glucose monitoring devices market 2018 - 2022 ($ million)
    • 4.2 Product Segment Analysis 2018 - 2022
      • Exhibit 19: Historic Market Size – Product Segment 2018 - 2022 ($ million)
    • 4.3 End-user Segment Analysis 2018 - 2022
      • Exhibit 20: Historic Market Size – End-user Segment 2018 - 2022 ($ million)
    • 4.4 Geography Segment Analysis 2018 - 2022
      • Exhibit 21: Historic Market Size – Geography Segment 2018 - 2022 ($ million)
    • 4.5 Country Segment Analysis 2018 - 2022
      • Exhibit 22: Historic Market Size – Country Segment 2018 - 2022 ($ million)

    5 Five Forces Analysis

    • 5.1 Five forces summary
      • Exhibit 23: Five forces analysis - Comparison between 2023 and 2028
    • 5.2 Bargaining power of buyers
      • Exhibit 24: Chart on Bargaining power of buyers – Impact of key factors 2023 and 2028
    • 5.3 Bargaining power of suppliers
      • Exhibit 25: Bargaining power of suppliers – Impact of key factors in 2023 and 2028
    • 5.4 Threat of new entrants
      • Exhibit 26: Threat of new entrants – Impact of key factors in 2023 and 2028
    • 5.5 Threat of substitutes
      • Exhibit 27: Threat of substitutes – Impact of key factors in 2023 and 2028
    • 5.6 Threat of rivalry
      • Exhibit 28: Threat of rivalry – Impact of key factors in 2023 and 2028
    • 5.7 Market condition
      • Exhibit 29: Chart on Market condition - Five forces 2023 and 2028

    6 Market Segmentation by Product

    • 6.1 Market segments
      • Exhibit 30: Chart on Product - Market share 2023-2028 (%)
      • Exhibit 31: Data Table on Product - Market share 2023-2028 (%)
    • 6.2 Comparison by Product
      • Exhibit 32: Chart on Comparison by Product
      • Exhibit 33: Data Table on Comparison by Product
    • 6.3 Wearable - Market size and forecast 2023-2028
      • Exhibit 34: Chart on Wearable - Market size and forecast 2023-2028 ($ million)
      • Exhibit 35: Data Table on Wearable - Market size and forecast 2023-2028 ($ million)
      • Exhibit 36: Chart on Wearable - Year-over-year growth 2023-2028 (%)
      • Exhibit 37: Data Table on Wearable - Year-over-year growth 2023-2028 (%)
    • 6.4 Non-wearable - Market size and forecast 2023-2028
      • Exhibit 38: Chart on Non-wearable - Market size and forecast 2023-2028 ($ million)
      • Exhibit 39: Data Table on Non-wearable - Market size and forecast 2023-2028 ($ million)
      • Exhibit 40: Chart on Non-wearable - Year-over-year growth 2023-2028 (%)
      • Exhibit 41: Data Table on Non-wearable - Year-over-year growth 2023-2028 (%)
    • 6.5 Market opportunity by Product
      • Exhibit 42: Market opportunity by Product ($ million)
      • Exhibit 43: Data Table on Market opportunity by Product ($ million)

    7 Market Segmentation by End-user

    • 7.1 Market segments
      • Exhibit 44: Chart on End-user - Market share 2023-2028 (%)
      • Exhibit 45: Data Table on End-user - Market share 2023-2028 (%)
    • 7.2 Comparison by End-user
      • Exhibit 46: Chart on Comparison by End-user
      • Exhibit 47: Data Table on Comparison by End-user
    • 7.3 Home care settings - Market size and forecast 2023-2028
      • Exhibit 48: Chart on Home care settings - Market size and forecast 2023-2028 ($ million)
      • Exhibit 49: Data Table on Home care settings - Market size and forecast 2023-2028 ($ million)
      • Exhibit 50: Chart on Home care settings - Year-over-year growth 2023-2028 (%)
      • Exhibit 51: Data Table on Home care settings - Year-over-year growth 2023-2028 (%)
    • 7.4 Hospitals - Market size and forecast 2023-2028
      • Exhibit 52: Chart on Hospitals - Market size and forecast 2023-2028 ($ million)
      • Exhibit 53: Data Table on Hospitals - Market size and forecast 2023-2028 ($ million)
      • Exhibit 54: Chart on Hospitals - Year-over-year growth 2023-2028 (%)
      • Exhibit 55: Data Table on Hospitals - Year-over-year growth 2023-2028 (%)
    • 7.5 Clinics - Market size and forecast 2023-2028
      • Exhibit 56: Chart on Clinics - Market size and forecast 2023-2028 ($ million)
      • Exhibit 57: Data Table on Clinics - Market size and forecast 2023-2028 ($ million)
      • Exhibit 58: Chart on Clinics - Year-over-year growth 2023-2028 (%)
      • Exhibit 59: Data Table on Clinics - Year-over-year growth 2023-2028 (%)
    • 7.6 Market opportunity by End-user
      • Exhibit 60: Market opportunity by End-user ($ million)
      • Exhibit 61: Data Table on Market opportunity by End-user ($ million)

    8 Customer Landscape

    • 8.1 Customer landscape overview
      • Exhibit 62: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

    9 Geographic Landscape

    • 9.1 Geographic segmentation
      • Exhibit 63: Chart on Market share by geography 2023-2028 (%)
      • Exhibit 64: Data Table on Market share by geography 2023-2028 (%)
    • 9.2 Geographic comparison
      • Exhibit 65: Chart on Geographic comparison
      • Exhibit 66: Data Table on Geographic comparison
    • 9.3 North America - Market size and forecast 2023-2028
      • Exhibit 67: Chart on North America - Market size and forecast 2023-2028 ($ million)
      • Exhibit 68: Data Table on North America - Market size and forecast 2023-2028 ($ million)
      • Exhibit 69: Chart on North America - Year-over-year growth 2023-2028 (%)
      • Exhibit 70: Data Table on North America - Year-over-year growth 2023-2028 (%)
    • 9.4 Europe - Market size and forecast 2023-2028
      • Exhibit 71: Chart on Europe - Market size and forecast 2023-2028 ($ million)
      • Exhibit 72: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
      • Exhibit 73: Chart on Europe - Year-over-year growth 2023-2028 (%)
      • Exhibit 74: Data Table on Europe - Year-over-year growth 2023-2028 (%)
    • 9.5 Asia - Market size and forecast 2023-2028
      • Exhibit 75: Chart on Asia - Market size and forecast 2023-2028 ($ million)
      • Exhibit 76: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
      • Exhibit 77: Chart on Asia - Year-over-year growth 2023-2028 (%)
      • Exhibit 78: Data Table on Asia - Year-over-year growth 2023-2028 (%)
    • 9.6 Rest of World (ROW) - Market size and forecast 2023-2028
      • Exhibit 79: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
      • Exhibit 80: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
      • Exhibit 81: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
      • Exhibit 82: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
    • 9.7 US - Market size and forecast 2023-2028
      • Exhibit 83: Chart on US - Market size and forecast 2023-2028 ($ million)
      • Exhibit 84: Data Table on US - Market size and forecast 2023-2028 ($ million)
      • Exhibit 85: Chart on US - Year-over-year growth 2023-2028 (%)
      • Exhibit 86: Data Table on US - Year-over-year growth 2023-2028 (%)
    • 9.8 Germany - Market size and forecast 2023-2028
      • Exhibit 87: Chart on Germany - Market size and forecast 2023-2028 ($ million)
      • Exhibit 88: Data Table on Germany - Market size and forecast 2023-2028 ($ million)
      • Exhibit 89: Chart on Germany - Year-over-year growth 2023-2028 (%)
      • Exhibit 90: Data Table on Germany - Year-over-year growth 2023-2028 (%)
    • 9.9 UK - Market size and forecast 2023-2028
      • Exhibit 91: Chart on UK - Market size and forecast 2023-2028 ($ million)
      • Exhibit 92: Data Table on UK - Market size and forecast 2023-2028 ($ million)
      • Exhibit 93: Chart on UK - Year-over-year growth 2023-2028 (%)
      • Exhibit 94: Data Table on UK - Year-over-year growth 2023-2028 (%)
    • 9.10 India - Market size and forecast 2023-2028
      • Exhibit 95: Chart on India - Market size and forecast 2023-2028 ($ million)
      • Exhibit 96: Data Table on India - Market size and forecast 2023-2028 ($ million)
      • Exhibit 97: Chart on India - Year-over-year growth 2023-2028 (%)
      • Exhibit 98: Data Table on India - Year-over-year growth 2023-2028 (%)
    • 9.11 China - Market size and forecast 2023-2028
      • Exhibit 99: Chart on China - Market size and forecast 2023-2028 ($ million)
      • Exhibit 100: Data Table on China - Market size and forecast 2023-2028 ($ million)
      • Exhibit 101: Chart on China - Year-over-year growth 2023-2028 (%)
      • Exhibit 102: Data Table on China - Year-over-year growth 2023-2028 (%)
    • 9.12 Market opportunity by geography
      • Exhibit 103: Market opportunity by geography ($ million)
      • Exhibit 104: Data Tables on Market opportunity by geography ($ million)

    10 Drivers, Challenges, and Trends

    • 10.1 Market drivers
      • 10.2 Market challenges
        • 10.3 Impact of drivers and challenges
          • Exhibit 105: Impact of drivers and challenges in 2023 and 2028
        • 10.4 Market trends

          11 Vendor Landscape

          • 11.1 Overview
            • 11.2 Vendor landscape
              • Exhibit 106: Overview on Criticality of inputs and Factors of differentiation
            • 11.3 Landscape disruption
              • Exhibit 107: Overview on factors of disruption
            • 11.4 Industry risks
              • Exhibit 108: Impact of key risks on business

            12 Vendor Analysis

            • 12.1 Vendors covered
              • Exhibit 109: Vendors covered
            • 12.2 Market positioning of vendors
              • Exhibit 110: Matrix on vendor position and classification
            • 12.3 Abbott Laboratories
              • Exhibit 111: Abbott Laboratories - Overview
              • Exhibit 112: Abbott Laboratories - Business segments
              • Exhibit 113: Abbott Laboratories - Key news
              • Exhibit 114: Abbott Laboratories - Key offerings
              • Exhibit 115: Abbott Laboratories - Segment focus
            • 12.4 Ascensia Diabetes Care Holdings AG
              • Exhibit 116: Ascensia Diabetes Care Holdings AG - Overview
              • Exhibit 117: Ascensia Diabetes Care Holdings AG - Product / Service
              • Exhibit 118: Ascensia Diabetes Care Holdings AG - Key offerings
            • 12.5 BoydSense SAS
              • Exhibit 119: BoydSense SAS - Overview
              • Exhibit 120: BoydSense SAS - Product / Service
              • Exhibit 121: BoydSense SAS - Key offerings
            • 12.6 Cnoga
              • Exhibit 122: Cnoga - Overview
              • Exhibit 123: Cnoga - Product / Service
              • Exhibit 124: Cnoga - Key offerings
            • 12.7 Dexcom Inc.
              • Exhibit 125: Dexcom Inc. - Overview
              • Exhibit 126: Dexcom Inc. - Product / Service
              • Exhibit 127: Dexcom Inc. - Key news
              • Exhibit 128: Dexcom Inc. - Key offerings
            • 12.8 DiaMonTech AG
              • Exhibit 129: DiaMonTech AG - Overview
              • Exhibit 130: DiaMonTech AG - Product / Service
              • Exhibit 131: DiaMonTech AG - Key offerings
            • 12.9 Gluco Rx Ltd.
              • Exhibit 132: Gluco Rx Ltd. - Overview
              • Exhibit 133: Gluco Rx Ltd. - Product / Service
              • Exhibit 134: Gluco Rx Ltd. - Key offerings
            • 12.10 F. Hoffmann La Roche Ltd.
              • Exhibit 135: F. Hoffmann La Roche Ltd. - Overview
              • Exhibit 136: F. Hoffmann La Roche Ltd. - Business segments
              • Exhibit 137: F. Hoffmann La Roche Ltd. - Key news
              • Exhibit 138: F. Hoffmann La Roche Ltd. - Key offerings
              • Exhibit 139: F. Hoffmann La Roche Ltd. - Segment focus
            • 12.11 Medtronic Plc
              • Exhibit 140: Medtronic Plc - Overview
              • Exhibit 141: Medtronic Plc - Business segments
              • Exhibit 142: Medtronic Plc - Key news
              • Exhibit 143: Medtronic Plc - Key offerings
              • Exhibit 144: Medtronic Plc - Segment focus
            • 12.12 Meta Materials Inc.
              • Exhibit 145: Meta Materials Inc. - Overview
              • Exhibit 146: Meta Materials Inc. - Product / Service
              • Exhibit 147: Meta Materials Inc. - Key offerings
            • 12.13 Nemaura Medical Inc.
              • Exhibit 148: Nemaura Medical Inc. - Overview
              • Exhibit 149: Nemaura Medical Inc. - Product / Service
              • Exhibit 150: Nemaura Medical Inc. - Key offerings
            • 12.14 Platinum Equity Advisors LLC
              • Exhibit 151: Platinum Equity Advisors LLC - Overview
              • Exhibit 152: Platinum Equity Advisors LLC - Product / Service
              • Exhibit 153: Platinum Equity Advisors LLC - Key offerings
            • 12.15 Rite Aid Corp.
              • Exhibit 154: Rite Aid Corp. - Overview
              • Exhibit 155: Rite Aid Corp. - Business segments
              • Exhibit 156: Rite Aid Corp. - Key offerings
              • Exhibit 157: Rite Aid Corp. - Segment focus
            • 12.16 Taiwan Biophotonic Co.
              • Exhibit 158: Taiwan Biophotonic Co. - Overview
              • Exhibit 159: Taiwan Biophotonic Co. - Product / Service
              • Exhibit 160: Taiwan Biophotonic Co. - Key offerings
            • 12.17 Walgreens Boots Alliance Inc.
              • Exhibit 161: Walgreens Boots Alliance Inc. - Overview
              • Exhibit 162: Walgreens Boots Alliance Inc. - Business segments
              • Exhibit 163: Walgreens Boots Alliance Inc. - Key offerings
              • Exhibit 164: Walgreens Boots Alliance Inc. - Segment focus

            13 Appendix

            • 13.1 Scope of the report
              • 13.2 Inclusions and exclusions checklist
                • Exhibit 165: Inclusions checklist
                • Exhibit 166: Exclusions checklist
              • 13.3 Currency conversion rates for US$
                • Exhibit 167: Currency conversion rates for US$
              • 13.4 Research methodology
                • Exhibit 168: Research methodology
                • Exhibit 169: Validation techniques employed for market sizing
                • Exhibit 170: Information sources
              • 13.5 List of abbreviations
                • Exhibit 171: List of abbreviations

              Research Framework

              Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

              INFORMATION SOURCES

              Primary sources

              • Manufacturers and suppliers
              • Channel partners
              • Industry experts
              • Strategic decision makers

              Secondary sources

              • Industry journals and periodicals
              • Government data
              • Financial reports of key industry players
              • Historical data
              • Press releases

              DATA ANALYSIS

              Data Synthesis

              • Collation of data
              • Estimation of key figures
              • Analysis of derived insights

              Data Validation

              • Triangulation with data models
              • Reference against proprietary databases
              • Corroboration with industry experts

              REPORT WRITING

              Qualitative

              • Market drivers
              • Market challenges
              • Market trends
              • Five forces analysis

              Quantitative

              • Market size and forecast
              • Market segmentation
              • Geographical insights
              • Competitive landscape

              PURCHASE FULL REPORT OF

              non-invasive glucose monitoring devices market market

              QUICK BUY

              Key Questions Answered

              • What are the key global market and the regional market share?
              • What are the revenue-generating key market segments?
              • What are the key factors driving and challenging this market’s growth?
              • Who are the key market vendors and their growth strategies?
              • What are the latest trends influencing the growth of this market?
              • What are the variables influencing the market growth in the primary regions?
              • What are the factors influencing the growth of the parent market?

              Why should you prefer Technavio's market insights report?

              • Off-the-shelf research reports
              • Reports can be tailored to meet the customer's needs
              • Trusted by more than 100 fortune 500 organizations
              • Information about the market's key drivers, trends, and challenges
              • Parent market analysis
              • Every week, 50,000 people visit our subscription platform
              • Detailed vendors report with competitive landscape
              • Covid-19 impact and recovery analysis
              • Data on revenue-generating market segments
              • Details on the market shares of various regions
              • Five-force market analysis